NCT05258825View on ClinicalTrials.gov

Preoperative Monoferric for Abdominal Surgery

PHASE4UnknownINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

March 31, 2023

Study Completion Date

April 30, 2023

Conditions

AnemiaSurgery

Interventions

DRUG

Monoferric

A single intravenous dose of 1000 mg of Monoferric will be administered to a patient 3-4 weeks before anticipated surgery.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

Pharmacosmos A/S

All Listed Sponsors

collaborator

Pharmacosmos A/S

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT05258825 - Preoperative Monoferric for Abdominal Surgery | Biotech Hunter | Biotech Hunter